Selected article for: "cc NC ND International license and previous study"

Author: Jiawen Hou; Jie Hong; Boyun Ji; Bowen Dong; Yue Chen; Michael P Ward; Wei Tu; Zhen Jin; Jian Hu; Qing Su; Wenge Wang; Zheng Zhao; Shuang Xiao; Jiaqi Huang; Wei Lin; Zhijie Zhang
Title: Changing transmission dynamics of COVID-19 in China: a nationwide population-based piecewise mathematical modelling study
  • Document date: 2020_3_30
  • ID: kuf8p4e1_48
    Snippet: We found that the estimated Ü´ value for COVID-19 in Wuhan was significantly higher than those reported for SARS and MERS. Since the estimated values are mostly between 2 and 3 for SARS 15 The number of cases in Wuhan in epidemic stages 1 and 2 might be substantially underreported due to various reasons. To address this problem, we designed a method to estimate the epidemic scale in the first two stages. Our numerical results demonstrate a large .....
    Document: We found that the estimated Ü´ value for COVID-19 in Wuhan was significantly higher than those reported for SARS and MERS. Since the estimated values are mostly between 2 and 3 for SARS 15 The number of cases in Wuhan in epidemic stages 1 and 2 might be substantially underreported due to various reasons. To address this problem, we designed a method to estimate the epidemic scale in the first two stages. Our numerical results demonstrate a large degree of underreporting with a similar conclusion to a previous study 6 and these exposed individuals likely became a major source of intra-or inter-provincial infection. Underreporting of exposed individuals could lead to an underestimation of infectious individuals in stages 1 and 2. Considering the rapidly increasing number of infectious individuals in Wuhan after January 23, 2020, our . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC ND International license and epidemic stage: 1, 2, 3, 4, 5, 6, 7
    • cc NC ND International license and infectious individual: 1, 2, 3, 4
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and major source: 1
    • cc NC ND International license and previous study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cc NC ND International license and problem address: 1, 2
    • cc NC ND International license and rapidly increase: 1, 2
    • cc NC ND International license and rapidly increase number: 1
    • epidemic scale and infectious individual: 1, 2
    • epidemic scale and International license: 1, 2, 3, 4
    • epidemic scale and large degree: 1
    • epidemic stage and estimate value: 1, 2
    • epidemic stage and infectious individual: 1, 2, 3
    • epidemic stage and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • epidemic stage and major source: 1, 2, 3
    • epidemic stage and previous study: 1
    • epidemic stage and problem address: 1
    • estimate value and International license: 1, 2
    • estimate value and previous study: 1, 2